ArticleBMJ open2026

Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial.

Karsten Große et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.